Improved treatment outcome for patients with common musculoskeletal disorders such as neck, shoulder, low back, hip, knee and multisite pain Musculoskeletal Diseases
Conditions
Interventions
To implement personalized care, we will employ innovative methods from artificial intelligence (AI) in terms of Case-Based Reasoning (CBR) to build a clinical decision support system (cDSS) based on p
Sponsors
Norwegian University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 110 Years
Inclusion criteria
Inclusion criteria: 1. Patients presenting to a primary care physiotherapist with musculoskeletal pain disorder in any of these areas; shoulder, neck, upper/low back, hip, knee or with multisite pain as primary contact reason. 2. Age above 18 years 3. Physiotherapists with the patient participants in their current patient population
Exclusion criteria
Exclusion criteria: 1. Reduced cognitive function or skills in Norwegian (impeding reading, speaking or comprehension of Norwegian language) 2. Neurological diagnosis (e.g. multiple sclerosis, stroke, ALS, Parkinson, dementia) 3. On-going cancer 4. Pregnancy or pregnancy-related disorders 5. Scheduled for surgery or recent surgery or fracture within the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patients' assessment of their condition measured by Global perceived effect (GPE), a seven-point Likert scale, at 3, 6 and 12 months. The GPE scale will be dichotomized as “improved” (score 1-2) or "unchanged/worse" (score 3-7). 2. Clinically important improvement in function, measured by the Patient Specific Function Scale (PSFS; 0-10), where a 30% change is defined as a Minimal clinically important difference (MCID). PSFS will be measured at baseline, 2, 4, 8 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| At baseline and 3, 6 and 12 month follow-up secondary outcomes include: 1. Pain intensity (NRS; 0-10) 2. Pain drawing, number of pain sites 3. Pain mapping; how often, continuous (of and on), daily variation 4. EQ-5D-5L (quality of life), five items 5. 15D (health-related quality of life, two items; sleep and vitality 6. Musculoskeletal Health Questionnaire (MSK-HQ) 7. Number of treatments by 3 months (patient records) 8. Patient-specific functional scale (PSFS; 0-10) 9. Work ability (single item from Work Ability Index; current work ability compared with life-time best 10. Work status/sick leave (patient records) 11. Medication (patient records) 12. Patient-therapist relationship (3 questions); overall satisfaction, belief in therapist's competency, and communication 13. Benefits of physiotherapy and expectations to physiotherapist (2 questions) 14. Adherence to treatment plan (5 alternatives) 15. Goal achievement (not, partly, or fully achieved) (patient records) 16. Most important reason for success/non-success (text), at 3 months only 17. Still receiving physiotherapy after 3, 6 and 12 months (yes/no) 18. Physical activity, 3 questions; frequency, intensity and duration 19. Hopkins Symptom Check List, HSCL-10 (emotional distress) 20. Pain Self efficacy, 2 questions (from PSEQ 2-item) 21. Cost-utility based on patients deductibles and costs covered by the Norwegian Health Economics Administration (HELFO) and utility measured by EQ-5D At 2, 4 and 8 weeks secondary outcomes collected by SMS (text-messages): 1. Patient-specific functional scale 2. Work ability 3. Global perceived effect score 4. Pain intensity, at 2 and 8 weeks only 5. Pain self-efficacy, at 2 and 8 weeks only | — |
Countries
Norway
Outcome results
None listed